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Background: Coronary artery disease (CAD) is and will remain the ¿ rst 
cause of death worldwide. As mortality after acute coronary syndromes has 
considerably decreased, there are more and more patients with chronic coro-
nary artery disease, with or without angina. Currently, most information on 
the characteristics, management, and outcomes of patients with chronic stable 
CAD comes from highly selected patient populations enrolled in randomized 
clinical trials or from hospital based cohorts. The purpose of the large inter-
national observational CLARIFY registry is to better characterize stable coro-
nary patients.
Methods: Between November 2009 and July 2010, CLARIFY enrolled 
more than 33 000 outpatients with stable CAD de¿ ned as history of docu-
mented myocardial infarction (>3 months), prior coronary revascularization, 
chest pain with documented myocardial ischemia or coronary stenosis of 
>50% proven by angiography, with 2428 patients included in France. 
Medical history, risk factors, demographic information, and management 
have been collected at baseline, and clinical events that occur during the 
follow- up period of up to 5 years in duration will be recorded. Establishing 
the determinants of prognosis and particularly the impact of resting heart rate 
is among the main goals.
Results: Complete results on the characteristics and management of the 
French population at baseline will be available and presented at the time of 
the meeting.
Conclusion: This analysis will present baseline characteristics of the 
French population included in the CLARIFY registry population and will esta-
blish comparisons with populations included in other countries.
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During atherogenesis, excess amounts of LDL accumulate in the suben-
dothelial space where they undergo oxidative modi¿ cations. Oxidized LDL 
(oxLDL) display many atherogenic properties including foam cell formation, 
inÀ ammatory response and apoptosis. OxLDL may alter the fragile balance 
between survival and death of vascular SMC (VSMC) thereby leading to 
plaque instability and ¿ nally to atherothrombotic events. Members of the 
protein kinase C family have been shown to exhibit pro- and anti- apoptotic 
activities, the PKC delta isoenzyme has been identi¿ ed in many studies as 
pro- apoptotic isoform.
The aim of this work was to investigate the role of PKC delta in the apop-
tosis of VSMC induced by oxLDL. We report that in human VSMC, oxLDL 
induce PKC delta activation as shown by its phosphorylation on Tyr311 and 
nuclear translocation. The phosphorylation on Tyr311 depends on the oxida-
tive stress generated by oxLDL because of its inhibition by the use of anti- 
oxidant molecules. Moreover, mouse embryonic ¿ broblasts invalidated for 
PKC delta (MEF PKC delta - /- ) show a strong resistance to cell death induced 
by oxLDL. We show that PKC delta interfaces with downstream pro- apoptotic 
endoplasmic reticulum stress (ER stress) to regulate the apoptotic machi-
nery. Indeed, in apoptotic cells phosphorylation of JNK, extracellular signal- 
regulated kinase, appears to be regulated in part by PKC delta. By contrast the 
ER stress pro- apoptotic factor CHOP is not involved in PKC delta- mediated 
apoptosis upon oxLDL stimulation. 
Altogether our results indicate that PKC delta plays a key role in the regu-
lation of ER stress- mediated cell death in VSMC which contributes to athero-
sclerotic plaque instability and rupture.
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Introduction: Spontaneous coronary artery dissection(SCAD), ¿ rst 
reported by Pretty in 1931,is a rare, but increasingly reported cause of acute 
coronary syndromes and sudden death. Its etiology and treatment have not yet 
been well de¿ ned.
Purpose: To study the angiographic and clinic outcome of the SCAD.
Methods: Retrospective analysis between 2005 and 2011 year of 7 patients 
diagnosed with SCAD in the departement of cardiology, Habib Thameur 
hospital.
Results: We report the observations of 7 patients with acute myocardial 
infarction managed in our service and explored by coronary angiography. 
They were 5 men and 2 women, with mean age of 46.5 years, in whom SCAD 
had been identi¿ ed as ¿ nal etiology for the ACS.
The cardiovascular risk factor was smoking in all patients; associated to 
hypertension in only one case. Thrombolysis had been performed in 5 patients 
and the coronary angiography carried out there after showed a dissection of 
the Left Anterior Descending artery (LAD) in 5 cases, the Obtuse Marginal 
(OM) in the other case and the remaining had coronary dissection in two sites 
of LAD and left main coronary artery( LCA).
All patients received immediately medical treatment including aspirin, 
clopidogrel and LMWH and were controlled after one month. 4 patients had 
a favorable outcome with a complete healing of the dissection with a near 
normal artery at the control and the 3 others had a residual stenosis or persis-
tant dissection treated with stenting.
Conclusion: SCAD is a rare entity. In patients with few classic risk factors 
for coronary heart disease presenting with an acute coronary syndrome, SCAD 
should imperatively be taken into consideration as a possible diagnosis. A 
complete healing of the SCAD can occur avoiding angioplasty and stent in 
such a young patients.
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Introduction: The objective of this study is to analyze predictive factors for 
left intraventricular thrombus constitution in the post myocardial infarction.
Material and Methods: Left ventricular aneurysm, dyskinesia and atrial 
¿ brillation were the exclusion criteria. Characteristics of selected patients 
(Group I: n=164) were compared to those of a witness group (Group II: 
n=164) presenting with myocardial infarction non complicated by thrombus.
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Results: Group I patients were managed much later than those of Group II 
(58h vs. 22h). Anterior topography was more frequent on Group I compared to 
Group II (100%vs 63%).There was no signi¿ cant difference concerning mean 
age, cardiovascular risk factors and coronary lesions diffusion. However, left 
ventricle was no more dilated on the ¿ rst group compared to the second.
Conclusion: It follows from the study that left ventricle dilation, reperfu-
sion therapy lack and delay of caring are factors exposing for left ventricle 
thrombus constitution. Patients ful¿ lling these criteria should take bene¿ t from 
prophylactic long course anticoagulant treatment.
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Diabetes is a major risk factor for cardiovascular morbidity and mortality 
including ischemic heart disease, which apart from its high frequency, is insi-
dious and severe.
The aim of our study is to determine the clinical, angiographic characteristics, 
treatment and outcome of acute coronary syndromes in the diabetic population.
From December 2010 to October 2011 we conducted a prospective study 
including 120 patients admitted to the cardiology department of Military 
Hospital Med V Rabat for acute coronary syndrome. These patients are 
divided into 50 diabetic patients and 70 patients without diabetes.
The comparison between the two groups shows that there are more males 
among diabetic patients. Hypertension and dyslipidemia are more frequently 
associated with diabetic patients. Chronic smoking is similar in both groups.
The clinical presentation is dominated by the ST negative acute coronary syn-
drome among the diabetic population. The frequency of left ventricular dysfunc-
tion studied by transthoracic echocardiography rest is similar in both groups.
The study of the coronary angiography is used to record a frequency of 
affected tri truncal diabetic patients (D) compared to non diabetic subjects 
(ND), conversely affection of mono truncal is more common in subjects ND. 
The frequency of the affection of small coronary arteries (diagonal, marginal) 
and distal segments is greater in diabetic subjects. The frequency of the affec-
tion of the common trunk of the left coronary artery is not different between the 
two groups. Finally, the coronary system is smaller in size in diabetic patients.
Medical treatment was similar in both groups; myocardial revascularization 
involved 30 patients from the entire study population with no difference regar-
ding the method of revascularization (angioplasty or coronary artery bypass 
graft surgery)
The poor prognosis of coronary disease in diabetic patients is due to the 
severity of coronary lesions. The intense resistance against cardiovascular risk 
factors, the development of means of revascularization and a closer collabo-
ration between cardiologists and endocrinologists will improve the prognosis.
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Objectives: We assessed the impact of invasive strategy (IS) versus a 
conservative strategy (CS) on in- hospital complications and three- year out-
comes in patients with Non- ST- Elevation Myocardial Infarction (NSTEMI) 
from the FAST- MI registry.
Background: Results from randomized trials comparing IS and CS in 
patients with NSTEMI are conÀ icting.
Methods: Of the 3,059 patients in the FAST- MI registry, which included 
patients with acute myocardial infarction (within 48 hours) over a one- month 
period in France at the end of 2005, 1,645 presented with NSTEMI.
Results: Of the 1,645 patients analyzed, 80% bene¿ ted from an IS. Patients 
in the IS group were younger (67±12 vs. 80±11 years), less often women 
(29% vs. 51%) and had a lower GRACE risk score (137±36 vs. 178±34) as 
compared with patient treated with CS. In- hospital mortality and blood trans-
fusions were signi¿ cantly more frequent in patients with CS as compared with 
IS (13.1 vs. 2.0%, 9.1 vs. 4.6%). Use of IS was associated with a signi¿ cant 
reduction in 3- year mortality and cardiovascular death (83 vs. 40%, adjusted 
HR: 0.44; 95%CI: 0.35- 0.55 and 92 vs. 64%, adjusted HR: 0.37; 95%CI: 0.27- 
0.50). After propensity score matching (181 patients per group), 3- year sur-
vival was signi¿ cantly higher in patients treated with IS. 
Conclusions: In a real- world setting of patients admitted with NSTEMI, 
the use of IS during the initial hospital stay is an independent predictor of 
improved 3- year survival, regardless of age
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Introduction: Tumor necrosis factor- alpha (TNF) could have dual effect on 
myocardial infarction when injected before coronary artery occlusion. Whether 
some studies have shown that TNF was cardioprotective, other experiment 
indicated that it could be harmful to the ischemic myocardium. To explain this 
controversial issue, we have designed a porcine model of myocardial infarc-
tion (MI) and assessed different doses of TNF on myocardial infarction.
Material and methods: Male pigs (35- 40kg) underwent MI by the occlusion 
of the left anterior descending artery just distal to the second diagonal branch by 
inÀ ated balloon catheter for 50min followed by a period of reperfusion (R). MI 
size (IS) expressed as percent of area at risk (AR) was estimated after 3h of R. 
Five groups were performed during this study. In the placebo group (P), normal 
saline was injected 15min. before the ischemic period. Three different doses of 
TNF (0.1, 1 & 3 g/kg (TNF 0.1, TNF 1 & TNF 3) were given 15min before 
the ischemic period in the coronary artery. In the preconditioning group (IPC), 
4 brief occlusions of 1min followed by 2min of R were performed before the 
ischemic period. In a subgroup of animal, activities of the caspase- 3 and - 8 were 
performed in the ischemic myocardium after 15min of R.
Results: We observed a signi¿ cant reduction of infarct size in the TNF 0.1, 
TNF 1 and IPC group but not in the TNF 3 versus P group. Caspase- 3 and - 8 
activities were signi¿ cantly reduced (30%) in the TNF 0.1, TNF 1 and IPC 
as compared to the P group. No reduction in caspase- 3 and - 8 activities were 
observed in the TNF 3 group.
Conclusion: TNF at low doses could be cardioprotective for the ischemic 
myocardium by an anti- apoptotic mechanism. However, when a higher dose 
of TNF was used, the bene¿ cial effect is lost.
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Leukocyte in¿ ltration in ischemic areas is a hallmark of myocardial 
infarction (MI). Although B cells are potent regulators of immunity in 
several immune- mediated diseases, their role in this setting remains unde-
termined. In a mouse model of MI, cardiac B cells levels peaked at day 
5 after the onset of infarction. Of interest, treatment with a CD20- speci¿ c 
monoclonal antibody decreased circulating and in¿ ltrating B cell numbers, 
reduced infarct size and post- ischemic immunoinÀ ammatory response, and 
improved cardiac function (p=0.02 vs control). Intriguingly, B cell depletion 
was associated with an impairment of Ly6Chi monocytes mobilization from 
bone marrow, leading to reduced levels of circulating and in¿ ltrating cardiac 
monocytes. The acute infarction led to transient increase of both MCP- 1 and 
MCP- 3 levels in blood and cardiac tissue. Interestingly, B cell depletion was 
associated with a signi¿ cant and selective reduction of MCP- 3 (p=0.03 vs 
control) but did not alter MCP- 1 levels (p=0.11). Cultured activated B cells 
released MCP- 3 and treatment with neutralizing MCP- 3 antibody abrogated 
B cell- induced migration of cultured monocytes. Finally, transfer of B cells- 
depleted splenocytes into Rag1- /- mice improved cardiac function after MI 
compared to the transfer of non- depleted splenocytes (p=0.005). This effect 
was abrogated after re- supplementation with B cells isolated from wild- 
type mice (p=0.0007) but not from MCP- 3- de¿ cient animals (p=0.7008). In 
conclusion, we show that following acute myocardial infarction, B lympho-
cytes, trigger an MCP- 3- dependent mobilization of Ly6Chi monocytes from 
the bone marrow to the blood, leading to their recruitment into the injured 
myocardium and to exacerbation of tissue inÀ ammation, thereby promoting 
adverse cardiac remodeling.
